Other
Blood Pressure
0
Pipeline Programs↗
13
Active Trials↗
25
Companies Involved↗
Blood Pressure is an early-stage landscape with 0 programs across 25 companies. The most active players are Merck & Co., Boehringer Ingelheim, Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
181
clinical trials
Completed125 · 69%
Unknown status24 · 13%
Terminated11 · 6%
Withdrawn8 · 4%
Recruiting5 · 3%
Active, not recruiting4 · 2%
Other4 · 2%
Clinical Trials
Trial Activity
181 trials
Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)
Recruiting·IInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran·Phase 4·NCT06380491·50 enrolled
Page 1 of 13
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)